Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PainReform ( (PRFX) ) has issued an update.
On January 5, 2026, PainReform announced that its DeepSolar business unit launched Smart TDD, a next-generation solar technical due diligence service designed to deliver faster, more accurate, and more comprehensive audits of solar asset performance and risk across the $60 billion-plus global solar asset M&A market. By offering full data coverage of components and operational history, AI- and physics-based diagnostics, clearly prioritized findings, and rapid turnaround times, Smart TDD aims to replace traditional sampling- and manual inspection-based approaches, supporting investors, independent power producers, infrastructure funds, operators, lenders, and insurers at key lifecycle points such as commissioning, underperformance diagnosis, warranty expiry, and asset transactions; the launch reinforces DeepSolar’s positioning as a trusted analytics partner in a rapidly growing and increasingly complex solar secondary market, where aging assets and accelerating deal activity are driving heightened demand for high-quality, scalable technical diligence services.
The most recent analyst rating on (PRFX) stock is a Hold with a $0.70 price target. To see the full list of analyst forecasts on PainReform stock, see the PRFX Stock Forecast page.
Spark’s Take on PRFX Stock
According to Spark, TipRanks’ AI Analyst, PRFX is a Neutral.
The score is driven primarily by very weak financial performance (minimal revenue, widening losses, and worsening cash burn with a shrinking equity cushion). Technicals also weigh on the score due to a clear downtrend versus key moving averages, partially offset by oversold indicators. Valuation contributes little support given negative earnings and no dividend yield.
To see Spark’s full report on PRFX stock, click here.
More about PainReform
PainReform Ltd. is a dual-focus company operating in both pharmaceuticals and energy technology. On the healthcare side, it reformulates established therapeutics using a proprietary extended-release drug-delivery system aimed at providing prolonged post-surgical pain relief while reducing reliance on opioids, with programs such as PRF-110 and OcuRing™-K. Through its DeepSolar platform, the company also develops AI-driven digital asset management and energy optimization solutions for utility-scale and solar-integrated environments, targeting both consumers and enterprises and positioning itself at the intersection of healthcare innovation and sustainable energy technology.
Average Trading Volume: 319,992
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.74M
See more data about PRFX stock on TipRanks’ Stock Analysis page.